Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranjit Manchanda

Showing results (51-60 of 162) with videos related to

Pageof 17
Sort By:
American Journal of Obstetrics and Gynecology|December 31, 2017
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish womenShreeya Patel, Rosa Legood, D Gareth Evans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?Ranjit Manchanda, Dhivya Chandrasekaran, Ertan Saridogan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 11, 2022
Variation in outcome reporting in studies of fertility-sparing surgery for cervical cancer: A systematic reviewNathanael Yong, Natalie Cooper, Sarah Yorke, et al.
Future Oncology (London, England)|November 25, 2024
Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023)Christina Fotopoulou, Rebecca Bowen, Ranjit Manchanda, et al.
American Journal of Obstetrics and Gynecology|April 14, 2023
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysisXia Wei, Samuel Oxley, Michail Sideris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2019
Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioral lifestyle program: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomized controlled pilot trialDimitrios A Koutoukidis, Rebecca J Beeken, Ranjit Manchanda, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 5, 2025
Borderline ovarian tumours: A comprehensive review of published evidenceKyriaki-Barbara Papalois, Michail Sideris, Samuel George Oxley, et al.
Nature Communications|November 23, 2024
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancerSamar Elorbany, Chiara Berlato, Larissa S Carnevalli, et al.
Familial Cancer|July 17, 2015
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UKDhivya Chandrasekaran, Usha Menon, Gareth Evans, et al.
Biomedical Signal Processing and Control|September 25, 2018
A quantitative performance study of two automatic methods for the diagnosis of ovarian cancerManuel A Vázquez, Inés P Mariño, Oleg Blyuss, et al.
Pageof 17

Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
American Journal of Obstetrics and Gynecology|December 31, 2017
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish womenShreeya Patel, Rosa Legood, D Gareth Evans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 15, 2015
Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?Ranjit Manchanda, Dhivya Chandrasekaran, Ertan Saridogan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 11, 2022
Variation in outcome reporting in studies of fertility-sparing surgery for cervical cancer: A systematic reviewNathanael Yong, Natalie Cooper, Sarah Yorke, et al.
Future Oncology (London, England)|November 25, 2024
Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023)Christina Fotopoulou, Rebecca Bowen, Ranjit Manchanda, et al.
American Journal of Obstetrics and Gynecology|April 14, 2023
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysisXia Wei, Samuel Oxley, Michail Sideris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 7, 2019
Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioral lifestyle program: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomized controlled pilot trialDimitrios A Koutoukidis, Rebecca J Beeken, Ranjit Manchanda, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|December 5, 2025
Borderline ovarian tumours: A comprehensive review of published evidenceKyriaki-Barbara Papalois, Michail Sideris, Samuel George Oxley, et al.
Nature Communications|November 23, 2024
Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancerSamar Elorbany, Chiara Berlato, Larissa S Carnevalli, et al.
Familial Cancer|July 17, 2015
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UKDhivya Chandrasekaran, Usha Menon, Gareth Evans, et al.
Biomedical Signal Processing and Control|September 25, 2018
A quantitative performance study of two automatic methods for the diagnosis of ovarian cancerManuel A Vázquez, Inés P Mariño, Oleg Blyuss, et al.
Pageof 17